Improving Equitable Access to Parkinson’s Disease Exercise Programs Through a Student-Led Transportation Model
Objective: To evaluate the feasibility and impact of a student-led transportation model designed to improve access to evidence-based exercise programs for people with Parkinson’s disease…Boosting cerebellum/M1 and PPC/M1 communication via tACS to improve cued gait in Parkinson’s disease patients unresponsive to auditory cueing strategies.
Objective: This study aims to test the contribution of Posterior Parietal Cortex – primary motor cortex and cerebellum - M1 pathways in decreasing gait variability…Disease Endophenotyping through Graph and Adjacency Metrics (DEGAS): Network Biomarkers for Parkinson’s Disease Prognosis
Objective: To develop a machine learning framework using resting-state functional connectivity to identify neural signatures of Parkinson's disease (PD) and forecast disease progression. Background: PD…Outcomes from Unilateral MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Advanced Parkinson’s Disease
Objective: To evaluate the safety, efficacy, and patient-reported outcomes of unilateral MRgFUS pallidothalamic tractotomy (PTT) for the treatment of aPD. Background: In July 2025, the…Can digital Mobility Outcomes differentiate cognitive impairment in Parkinson’s Disease?
Objective: To determine if digital mobility outcomes (DMOs) differentiate between those with and without cognitive impairment in Parkinson’s disease (PD). Background: Cognitive impairment is common…Lack of Association Between Polygenic Risk Scores for Parkinson’s Disease and Age at Onset, Freezing of Gait, or Psychosis
Objective: To evaluate whether the polygenic risk scores of Parkinson’s disease (PD-PRS) is associated with age at disease onset (AAO), freezing of gait (FOG) or…Association of Triglycerides, LDL, and IL-6 with Non-Motor Symptoms in Parkinson’s Disease: A Cross-Sectional Study
Objective: To analyze the association between serum levels of low-density lipoprotein (LDL), triglycerides, and interleukin-6 (IL-6) with non-motor symptoms in patients with Parkinson’s disease. Background:…Apparent Change Classification with Stage-Specific and Fixed Minimal Detectable Change Thresholds in Parkinson’s Disease
Objective: To compare whether stage-specific and fixed minimal detectable change (MDC) thresholds yield different classifications of apparent change in repeated within-session 10-meter walk test (10MWT)…Outcomes of Bilateral Deep Brain Stimulation Following Prior MR-guided Focused Ultrasound Thalamotomy
Objective: To evaluate the safety and efficacy of subsequent Deep Brain Stimulation (DBS) as a management strategy for patients with recurrent or residual symptoms following MR-guided Focused Ultrasound (MRgFUS) thalamotomy. Background: Despite its…Mobility Impairment And Balance Perception Discrepancy In Parkinson’s Disease
Objective: To describe mobility impairment, balance disturbances, and walking aid use in Parkinson’s disease (PD), and to examine discrepancies between subjective balance complaints and objective…
- « Previous Page
- 1
- …
- 63
- 64
- 65
- 66
- 67
- …
- 553
- Next Page »